Prima BioMed Becomes Immutep
November 27 2017 - 7:12PM
We refer to shareholder approval granted at the Company’s Annual
General Meeting held on 17 November 2017 to change the name of the
Company from ‘Prima BioMed Ltd’ to ‘Immutep Limited’.
The Company is pleased to advise that the name
Immutep Limited has been formally adopted after ASIC
registration.
The ASX has been informed and the Company will
trade under the new ticker IMM from 1 December 2017.
The Company will also trade under the NASDAQ ticker
of IMMP.
For further information please
contact:
U.S. Investors:Jay Campbell,
Vice President of Business Development and Investor Relations,
Prima BioMed+1 (917) 860-9404; jay.campbell@primabiomed.com.au
Matthew Beck, The Trout Group LLC+1 (646)
378-2933; mbeck@troutgroup.com
Australian
Investors/Media:Matthew Gregorowski, Citadel-MAGNUS+61 2
8234 0105; mgregorowski@citadelmagnus.com
Immutep Limited (NASDAQ:PBMD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Immutep Limited (NASDAQ:PBMD)
Historical Stock Chart
From Apr 2023 to Apr 2024